Rethinking radiation therapy in the era of RAS inhibition for pancreatic cancer
The Oncologist · 05.11.2026 · 31 (12)
DOI: 10.1093/oncolo/oyag433 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 28.10.2026. Verfasst von Michael D Chuong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Herbert Wertheim Cancer Center, Baptist Health South Florida, Miami, FL 33176, USA. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Herbert Wertheim Cancer Center, Baptist Health South Florida, Miami, FL 33176, USA.
- Department of Oncological Sciences, Florida International University Herbert Wertheim College of Medicine, Miami, FL 33199, USA.
- Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
ORCID-Profile: Michael D Chuong, Eileen M O'Reilly
Zitieren
APA
Chuong, M. D., & O'Reilly, E. M. (2026). Rethinking radiation therapy in the era of RAS inhibition for pancreatic cancer. The Oncologist, 31(12). https://doi.org/10.1093/oncolo/oyag433
Vancouver
Chuong MD, O'Reilly EM. Rethinking radiation therapy in the era of RAS inhibition for pancreatic cancer. The Oncologist. 2026;31(12). doi:10.1093/oncolo/oyag433
BibTeX
@article{Chuong2026,
author = {Chuong, Michael D and O'Reilly, Eileen M},
title = {Rethinking radiation therapy in the era of RAS inhibition for pancreatic cancer},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {12},
doi = {10.1093/oncolo/oyag433}
}
EUVIMED